CHPA and PCPC Comments Regarding Content and Format of Labeling for Human Nonprescription Drug Products Share page: Docket Number: FDA-2022-D-1837 Download Document Issues: OTC Medicines Other Issues Labeling Related Posts Press Releases and Statements CHPA Response to Study Examining Prescription Acid Reflux Drugs Apr 25, 2024 Articles Polibrief: Consumer Data Privacy: State Efforts to Preserve Privacy Apr 16, 2024 Press Releases and Statements Self-Care Industry Representatives Participate in Capitol Hill Briefing Highlighting Legislative Priorities Apr 11, 2024